Gland Pharma Ltd

About [ edit ]

Established in Hyderabad, India in 1978, Gland Pharma has grown over the years from a contract manufacturer of small volume liquid parenteral products, to become one of the largest and fastest growing injectable-focused companies, with a global footprint across 60 countries, including the United States, Europe, Canada, Australia, India and other markets. We operate primarily under a business to business (B2B) model and have an excellent track record in the development, manufacturing and marketing of complex injectables. This presence across the value chain has helped us witness exponential growth. We are promoted by Shanghai Fosun Pharma, a global pharmaceutical major.

Key Points [ edit ]
  • Market Cap 43,651 Cr.
  • Current Price 2,670
  • High / Low 2,693 / 1,831
  • Stock P/E 57.4
  • Book Value 242
  • Dividend Yield 0.00 %
  • ROCE 30.2 %
  • ROE 23.4 %
  • Face Value 1.00

Pros

  • Company has reduced debt.
  • Company is almost debt free.

Cons

  • Stock is trading at 11.01 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Jun 2019 Dec 2019 Jun 2020 Sep 2020 Dec 2020
674 646 884 832 859
411 434 472 534 595
Operating Profit 263 212 413 298 264
OPM % 39% 33% 47% 36% 31%
Other Income 34 25 32 20 35
Interest 0 6 0 1 1
Depreciation 22 24 24 25 25
Profit before tax 274 207 420 293 273
Tax % 33% 26% 25% 25% 25%
Net Profit 184 154 314 219 204
EPS in Rs
Notes Notes Notes Notes Notes

Profit & Loss

Figures in Rs. Crores

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
1,348 1,479 1,620 2,044 2,633
845 854 1,085 1,338 1,678
Operating Profit 502 625 535 706 955
OPM % 37% 42% 33% 35% 36%
Other Income 37 34 49 66 139
Interest 16 6 4 4 7
Depreciation 63 74 78 82 95
Profit before tax 459 578 502 686 993
Tax % 32% 28% 36% 34% 22%
Net Profit 314 414 321 452 773
EPS in Rs
Dividend Payout % 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years:%
5 Years:%
3 Years:21%
TTM:29%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:22%
TTM:63%
Stock Price CAGR
10 Years:%
5 Years:%
3 Years:%
1 Year:%
Return on Equity
10 Years:%
5 Years:%
3 Years:19%
Last Year:23%

Balance Sheet

Figures in Rs. Crores

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Jun 2020
15 16 16 16 16 16
Reserves 1,662 2,074 2,395 2,847 3,631 3,948
Borrowings 117 6 6 5 5 4
292 378 512 655 435 724
Total Liabilities 2,086 2,474 2,928 3,523 4,086 4,691
788 872 843 929 968 951
CWIP 202 161 199 123 188 254
Investments 0 0 0 0 0 0
1,096 1,441 1,887 2,471 2,929 3,486
Total Assets 2,086 2,474 2,928 3,523 4,086 4,691

Cash Flows

Figures in Rs. Crores

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
220 476 202 185 701
-12 -100 -359 -319 -761
-93 -116 -4 -3 -7
Net Cash Flow 115 260 -160 -136 -67

Ratios

Figures in Rs. Crores

Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
ROCE % 30% 22% 27% 30%
Debtor Days 95 103 107 90 83
Inventory Turnover 1.50 1.62 0.98 1.10

Shareholding Pattern

Numbers in percentages

Dec 2020
58.36
12.73
10.81
18.10

Documents

Add document